Israeli-American computer scientist, Coursera co-founder and former Stanford professor
Every podcast episode featuring Daphne Koller that Attunex has found: 60 interviews and appearances across 50 shows between 2009 and 2026. Most often on Meet The Leader (3), Raising Health (3) and The Genetics Podcast (2). Often in conversation with Elad Gil, Jacob Effron and Sarah Guo. Follow Daphne in Attunex to get new appearances automatically, each with an on-device transcript and summary.
Follow Daphne Koller in AttunexUpdated 2026-10-14.
Daphne Koller is enticing top universities to put their most intriguing courses online for free -- not just as a service, but as a way to research how people learn. With Coursera (cofounded by Andrew…
In this episode, we critically examine whether AI drug discovery is solving the hardest problems in medicine—or simply making the easier ones faster. At the center of the discussion is Daphne…
生成AIのコストは劇的に下がったのに、出てきたものを確かめる手間はほとんど安くなっていない。この回では、その非対称がどこから生まれ、放置するとどこに歪みが溜まるのかを整理する。「安くなった」という言葉に安心する前に聞いておきたい回。 AI Database —…
ボトルネックが解消された後も、それを測るために作った指標だけが組織に居座り続けることがある。移り変わる制約と、取り残された古い物差しのズレをどう見抜くかを考える回。「なぜこの数字をまだ追っているんだっけ」と一度でも思ったことがある人へ。 Daphne Koller (insitro) on the "key and lock" problem in AI drug discovery —…
Daphne Koller wrote the book that many of us learned probabilistic graphical models from, founded Coursera, and now runs insitro, which is trying to make drug discovery a machine-learning problem. We…
Tom interviews Daphne Koller, a Stanford professor turned serial entrepreneur. Daphne is widely known for her research at the intersection of machine learning and probabilistic reasoning. Daphne is a…
📈Our WYNDEX (What’s Your Number Index) update for today: Markets were up this week, but the WYNDEX slipped again. Yonatan and Yael break down the biggest movers, including Nova leading the pack and…
The AI boom wouldn’t have been possible without decades of academic research. And now that huge sums of money are flowing into R&D, it’s companies – not just universities – on the cutting edge of AI…
This week on The Genetics Podcast, we celebrate our 200th episode with a look back at some of the earliest episodes, particularly ones that foresaw major trends or went on to spark real-world impact.…
Daphne Koller, Noubar Afeyan, and Dr. Eric Topol, leaders in AI-driven medicine, discuss how AI is changing biomedical research and discovery, from accelerating drug target identification and biotech…
Daphne Koller, CEO of insitro and cofounder of Coursera, joins Leadership Next to unpack a bold idea: Just as calculus revolutionized our understanding of physics, AI could do the same for biology.…
This episode is part of our “Summer Selects” series—curated archival episodes that shifted our perspective and are worth revisiting. Daphne Koller—AI pioneer, founder of Coursera, and CEO of…
En un mundo donde el acceso a la educación superior sigue siendo un privilegio, Daphne Koller se convirtió en una de las figuras clave para democratizar el conocimiento a escala global. Cofundadora…
On this episode of Coder Caffeine, Maker Mantras Edition, we are guided by a powerful quote from Daphne Koller, the Co-Founder of Coursera, and practice a powerful mantra that reminds us that our…
Dean Lloyd Minor welcomes Daphne Koller, PhD, founder and CEO of insitro, for a conversation about AI’s potential to transform drug discovery. They discuss how machine learning algorithms can…
What's a piece of advice that changed you for the better? In this special episode of Meet The Leader, top leaders from Microsoft, to IKEA to the International Monetary Fund and more share the…
On this episode of Coder Caffeine we decode an uplifting quote from Daphne Koller, and provide a quick mental framework to transition from fearing the unknown, to understanding that the unknown holds…
Daphne Koller is an AI pioneer, MacArthur fellow, member of the National Academy of sciences and the founder and CEO of drug discovery and development company insitro. She'll talk about how attitudes…
How can scientists leverage AI and machine learning to more effectively research, develop, and deliver new drugs? This week, Reid and Aria talk drug development with renowned computer scientist and…
Artificial intelligence has the potential to massively improve human health: from developing new drugs to providing more accurate diagnoses and helping people who live with severe disabilities. But…
Few startup founders follow a path to success like Daphne Koller, a polymath whose academic career in machine learning, computer vision, and computational biology make her a force far beyond the…
Artificial intelligence has the potential to massively improve human health: from developing new drugs to providing more accurate diagnoses and helping people who live with severe disabilities. But…
In this episode of the AI Grand Rounds podcast, Dr. Daphne Koller charts her professional trajectory, tracing her early fascination with computers to her influential role in AI and health care.…
Artificial intelligence is transforming healthcare, unleashing new investment opportunities. From cancer screening to drug discovery, AI promises to augment clinical decision-making and improve care.…
Transcript Eric Topol ( 00:06 ): Well, hello, this is Eric Topol with Ground Truths and I am absolutely thrilled to welcome Daphne Koller, the founder and CEO of insitro, and a person who I've been…
Where do you see yourself and your team a year from now? How can you maximize tech - and mitigate its risks? How can you stay focused despite increasing geopolitical tensions? What impacts will small…
Generative AI is advancing exponentially. What is happening at the frontier of research and application and how are novel techniques and approaches changing the risks and opportunities linked to…
In this episode, we highlight the world changing contributions of Dr. Fei Fei Li and Dr. Daphne Koller.
We’re looking back on 2023 and sharing a handful of our favorite conversations. Last year was full of insightful conversations that shaped the way we think about the most innovative movements in the…
Bio Eats World is now Raising Health! Vijay Pande, founding partner of Bio + Health, is joined by Daphne Koller, Andrew Ng, Aviv Regev, and Jakob Uszkoreit. Vijay leads us on a reflective journey…
Generative AI is, by its very nature, a game-changer. It's not about automation; it's about amplification. It augments our abilities, pushing the boundaries of what's possible, transforming…
This episode is live from our recent AI Revolutionaries (AIR) conference. In this episode, Daphne Koller, founder and CEO at insitro and AI expert, chats with Vijay Pande of Bio + Health. You can…
Today’s episode continues our coverage from a16z’s recent AI Revolution event. You’ll hear a16z Bio & Health GP Vijay Pande speak with Daphne Koller about the fascinating convergence of machine…
Daphne Koller is the founder and CEO of insitro, a company using AI and machine learning to engineer drug discovery. In this conversation with a16z's Vijay Pande, she discusses how an LLM for cells…
This podcast is a commentary and does not contain any copyrighted material of the reference source. We strongly recommend accessing/buying the reference source at the same time. ■Reference Source…
Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery…
Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery…
In this episode, Daphne Koller, founder and CEO of insitro—as well as the co-founder of Coursera, a MacArthur Award winner, and a former professor in the department of computer science at Stanford…
Life-saving therapeutics continue to grow more costly to discover. At the same time, recent advances in using machine learning for the life sciences and medicine are extraordinary. Are we on the…
In this episode of Lexman Artificial, Lexman interviews Stanford computer scientist and entrepreneur Daphne Koller. They discuss the concept of nematoda, the use of adhesives in the chest, and the…
Lexman Artificial interviews Daphne Koller, one of the most successful entrepreneurs in Silicon Valley. They discuss her experiences founding two startups, how she manages her bankroll, and how she…
Daphne Koller was a precociously clever child. She completed her first degree – a double major in mathematics and computer science – when she was just 17 and went on to become a distinguished…
In the latest episode of the Lexman Artificial Podcast, Daphne Koller returns to talk all things granite arbitrage. She shares stories of her find in Israel and her observations of the international…
About this Episode: This week’s guest, Daphne Koller, is the Founder and CEO of Insitro - a company shifting the paradigm of new drug discovery using predictive models. Patrick and Daphne talk about…
Over time, drug development has become more and more challenging. Success rates of clinical trials hover in the single digits, and the cost of developing a new treatment is greater than $2.5B. So,…
Meet Daphne Koller, Ph.D.: Daphne Koller, Ph.D. is the founder and CEO of insitro, a company that aims to improve drug discovery and development through machine learning. She is also a co-founder and…
How does collaboration between machine learning and biomedicine spur AI innovation? How can these two scientific cultures compliment and support one another? In this AI Ignition episode, Daphne…
Daphne Koller is the CEO and founder of insitro, a machine learning-enabled drug discovery company. Previously, she was a professor of computer science at Stanford University for 18 years, co-founder…
This is the last episode of Season 1. Join us in the Fall for Season 2, and in the meantime, please take our brief survey! http://bit.ly/theaihealthpodcast Dr. Daphne Koller is CEO and Founder of…
From teaching at Stanford to co-founding Coursera, insitro, and Engageli, Daphne Koller reflects on the importance of education, giving back, and cross-functional research. Daphne Koller is the…
In a world where a drug takes years and billions of dollars to develop, just one in 20 candidates makes it to market. Daphne Koller is betting artificial intelligence can change that dynamic. Twenty…
Daphne Koller, CEO of insitro, on machine learning for drug discovery
Former Stanford University professor Daphne Koller's cutting edge work combines machine learning and biology to transform pharmaceutical drug development. Her work at insitro is part of an emerging…
Follow Daphne: https://twitter.com/DaphneKoller Check out insitro: https://insitro.com/ Follow Jason: https://linktr.ee/calacanis
What does a hybrid team working at the interface of machine learning and biomedicine look like? In this episode, I chat with Daphne Koller, Founder and CEO of insitro, about a data-first approach to…
Daphne Koller is a professor of computer science at Stanford University, a co-founder of Coursera with Andrew Ng and Founder and CEO of insitro, a company at the intersection of machine learning and…
Professor Daphne Koller is the CEO and founder of insitro. She joins the podcast to discuss how machine learning and biology can advance drug discovery and patient care.
Today we’re joined by Daphne Koller, co-Founder and former co-CEO of Coursera and Founder and CEO of Insitro. In our conversation, discuss the current landscape of pharmaceutical drugs and drug…
Daphne Koller, formerly at Stanford University and cofounder of the online education company, Coursera, talks this week about using machine-learning to develop new drugs. Her approach is to use…
Watch Peter DeSantis, VP, AWS Global Infrastructure and Customer Support, deliver the Monday Night Live keynote, featuring Cris Collinsworth from PFF, Rob Smedley with Formula 1 and Daphne Koller,…
On GPS: After giving BILLIONS of his own fortune away to causes like education, polio, and malaria, Bill Gates tells Fareed what he makes of proposals to raise taxes on the wealthy. Then, Stanford…
In episode one of season five we talk about Bit by Bit, take a listener question on machine learning gatherings on the African continent (Deep Learning INDABA! DSA!) and hear an interview with Daphne…
Daphne Koller, co-founder of Coursera and professor of Computer Science at Stanford, joins Venrock's Tom Willerer to discuss her experience as a first-time founder. Daphne shares how her desire to…
with Atul Butte (@atulbutte), Daphne Koller (@daphnekoller), and Vijay Pande (@vijaypande) Whether you’re an academic seeking to move out of research and into industry, or simply interested in…
Coursera offers online courses to the public through partnerships with leading universities internationally. Coursera was launched in 2012 and reached its first one million users faster than Facebook…
Coursera’s Daphne Koller discusses plans for the future of a format that some thought would never last this long.
Coursera president and co-founder Daphne Koller talks with Recode's Kara Swisher about how she helped build the popular online learning platform after a successful early experiment at Stanford…
Coursera co-founder Daphne Koller talks with Knowledge at Wharton about how MOOCs can maintain momentum even though the flurry of attention surrounding them has died down. Hosted on Acast. See…
Daphne Koller of Coursera talks with EconTalk host Russ Roberts about online educational website Coursera and the future of education both online and via bricks-and-mortar. Koller, co-founder of…
Future Tense fellows Christine Rosen and Marvin Ammori discuss online education with Daphne Koller, the co-founder of Coursera, a digital learning platform. The panelists consider whether massive…
The 2014 Univ Access Lecture took place on Tuesday 17th June in Merton college. Professor Daphne Koller, co-founder of Coursera and Professor of Computer Science at Stanford University, discussed…
Massive open online courses (MOOCs) are shaking up traditional models of education. Among the most active providers of them today is Coursera a start-up that presents some 200 courses to 1.5 million…
Daphne Koller won a 2004 MacArthur Fellowship for her creativity in the area of artificial intelligence with her research on Bayesian methods, a once obscure branch of probability theory. (February…